Lead Optimization And Beyond
Optimizing the lead series through our machine learning augmented traditional molecular
models with focus on cellular activity, DMPK properties, exposure and PD







Image Slide 1
Image Slide 1
Image Slide 3
Image Slide 3
Image Slide 3
Image Slide 3
Image Slide 3
Multiparameter optimization driven iterative design of leads
ML models for cellular potency
Target engagement assessment
Identification of potential off targets based on our molecular similarity engine
Robust predictive models for CYPs and hERG
QSAR and ML models for PK/PD based on program data availability
Integrated model of in vitro, cellular and PK/PD leading to IVIVC understanding
Molecular hypotheses for observed AEs and mitigation plans